SaniTech India

COVAXIN

COVAXINTM, India's indigenous COVID-19 vaccine Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). This indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.

The vaccine received approval from Drug Controller General of India (DCGI) for Phase I & II Human Clinical Trials and an Adaptive, Seamless Phase I, Followed by Phase II Randomized, Double blind, Multicentre Study to Evaluate the Safety, Reactogenicity, Tolerability and Immunogenicity of the Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152).

Source- ICMR

Vaccine information, ICMR New delhi - COVID-19 Vaccine Vaccine, COVID-19 Vaccine, CoVaxin, ICMR Vaccine information

Sanitization is a must!!

Lancet says India putting ‘too positive spin’ on Covid data, warns against ‘false optimism’ The Lancet editorial praises India’s early lockdown, and says country’s leaders must capitalise on expertise in public health, research, and manufacturing to lead it through the pandemic.